Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Current Deferred Revenue (2020 - 2025)

Celularity (CELU) has disclosed Current Deferred Revenue for 6 consecutive years, with $5.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue rose 51.2% to $5.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.6 million, a 51.2% increase, with the full-year FY2024 number at $6.3 million, up 3.9% from a year prior.
  • Current Deferred Revenue was $5.6 million for Q3 2025 at Celularity, up from $3.5 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $11.9 million in Q1 2021 to a low of $3.5 million in Q2 2025.
  • A 5-year average of $5.6 million and a median of $4.7 million in 2023 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: tumbled 72.08% in 2021, then surged 51.2% in 2025.
  • Celularity's Current Deferred Revenue stood at $4.1 million in 2021, then grew by 10.45% to $4.5 million in 2022, then surged by 34.02% to $6.0 million in 2023, then grew by 3.9% to $6.3 million in 2024, then dropped by 10.73% to $5.6 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Current Deferred Revenue are $5.6 million (Q3 2025), $3.5 million (Q2 2025), and $6.3 million (Q1 2025).